Gene expression profiling of melatonin-treated bone cancer cells
This study explores how melatonin regulates anoikis resistance in bone cancer cells under suspension conditions. RNA sequencing was performed to analyse gene expression changes in non-adherent cells with or without melatonin treatment. The results indicate that melatonin suppresses SLC38A5 expression and alters glutamine metabolism and redox status.